South Korea - Lipid Modifying Medicine Use

Since 2014, South Korea Lipid Modifying Medicine Use jumped by 7.3% year on year. In 2019, the country was ranked number 25 among other countries in Lipid Modifying Medicine Use with 74.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. South Korea is overtaken by Latvia, which was number 24 with 92.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Estonia at 69.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark topped the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, an increase of 3.5% compared to 2018. United Kingdom, Norway and Belgium respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +18.8% per year, while Slovakia recorded the worst performance at -8.7% per year.

Loading...

Date Units (Defined Daily Dosage) Per Thousand Persons Per Day
2019 74.10
2018 72.40
2017 67.40
2016 63.10
2015 58.80
Download all data from 2008 to 2019

How does South Korea rank in Lipid Modifying Medicine Use?

# 28 Countries Units (Defined Daily Dosage) Per Thousand Persons Per Day Last YoY 5‑years CAGR
1 #1
Denmark
160 2019 +3.5 % +3.8 % View data
2 #2
United Kingdom
153 2019 +1.7 % +2.3 % View data
24 #24
Latvia
93 2019 +9.8 % +10.5 % View data
25 #25
South Korea
74 2019 +2.4 % +7.3 % View data
26 #26
Estonia
69 2019 +7.3 % +7.9 % View data
Compare all 28 countries

Go Top